MedPath

Treatment of Nasolacrimal duct obstructio

Not Applicable
Conditions
primary acquire nasolacrimal duct obstruction.
Acute and unspecified inflammation of lacrimal passages
Registration Number
IRCT201409166033N4
Lead Sponsor
Research Deputy of Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
51
Inclusion Criteria

All patient with primary acquire nasolacrimal duct obstruction Exclusion criteria: History of surgery on nasolacrimal duct, Secondary obstruction in nasolacrimal duct

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The degree of nasolacrimal duct obstruction. Timepoint: Every 6 weeks. Method of measurement: MUNK scoring system.
Secondary Outcome Measures
NameTimeMethod
Foreign body sensation. Timepoint: Every 6 weeks. Method of measurement: MUNK scoring system.
© Copyright 2025. All Rights Reserved by MedPath